ST LOUIS (MD Consult) - On August 6, 2010, the US Food and Drug Administration (FDA) announced that EZVille, Ltd has recalled Revivexxx Extra Strength, a product marketed as a dietary supplement for sexual enhancement in men. The decision to conduct the recall was made after the FDA informed the company that a product analysis revealed the presence of undeclared tadalafil. Tadalafil is an FDA-approved drug for the treatment of male erectile dysfunction, making Revivexxx Extra Strength an unapproved drug.
The FDA believes that the use of this product could pose a threat to consumers because tadalafil may interact with nitrates found in some prescription drugs (eg nitroglycerin) and may lower blood pressure to dangerous levels. However, no illnesses or injuries have been reported to the company to date in connection with this product.
Revivexxx Extra Strength is packaged in a single-dose blister pack containing 1 oral tablet and bears Universal Product Code 8 35470 00207 9. All lots of this product with expiration dates including and prior to August 2013 currently available on the market are being recalled. The company has discontinued distribution of the affected product.
Consumers are being advised to contact their physician if they have experienced any problems that may be related to use of this product. Health care professionals and patients are encouraged to report adverse events related to product use to the FDA's MedWatch Program.
圣路易斯(MD Consult)——美国食品药品管理局(FDA)于2010年8月6日宣布,EZVille公司决定召回其产品Revivexxx Extra Strength,该产品作为一种提高男性性欲的膳食补充剂在市场上销售。此次召回决定是在FDA正式通知该公司其产品含有未申明成分他达拉非(tadalafil)后作出的。他达拉非是FDA批准用于治疗男性勃起功能障碍(ED)的药物,因而Revivexxx Extra Strength被视为未经批准的药物。
FDA认为,服用该产品可能会给消费者构成威胁,因为他达拉非可与一些处方药物(如硝酸甘油)中的硝酸盐相互作用,从而导致血压降低至危险水平。然而截至目前为止,该公司尚未收到有关该产品所导致疾病或伤害的报告。
Revivexxx Extra Strength的包装形式为含有1片的单剂量泡罩包装,并印有通用产品代码8 35470 00207 9。目前市售的使用截止日期在2013年8月及其之前的所有批次产品均在召回之列。该公司已经停止相关产品配送。
建议消费者一旦出现任何可能与该产品使用有关的问题时,应与医生联系。鼓励医护人员和患者向FDA MedWatch Program系统报告与该产品使用有关的不良事件。